Getty Images, the stock photo agency with more than 135 million images on file, has premiered its own AI able to invent images in response to user requests.
Category: 10 October 2023
OPENAI MULLING SHARE SALE THAT WOULD TRIPLE ITS MARKET VALUE
OpenAI, the company that gave the world ChatGPT and started the current AI revolution, is asking investors’ opinions about issuing a new private round of stock, The Wall Street Journal reported. The new issue would likely value OpenAI at between $80 billion and $90 billion, people familiar told the WSJ.
IT SEES! IT SPEAKS! CHATGPT GETS NEW POWERS
An updated version of ChatGPT, the AI that launched the artificial intelligence revolution, will be able to “see, hear, and speak” with two new features, parent company OpenAI has announced.
SOFTBANK MAY PUT UP $1 BILLION TO CREATE SMARTPHONE BASED ON CHATGPT
Sam Altman, CEO of ChatGPT creator OpenAI, is in talks with Masayoshi Son, founder and CEO of Japanese venture fund Softbank, to back the development of “the iPhone of artificial intelligence,” according to three people familiar who told the Financial Times.
SNACK-MAKERS CONSIDER HOW BUSINESS COULD BE IMPACTED AS OZEMPIC GENERATION TAKES HOLD
Top food manufacturers see trouble on the horizon as more people take Ozempic, the diabetes drug that has proven useful for weight loss—despite reports of potentially fatal side effects.
AI DESIGNS A WALKING ROBOT IN 26 SECONDS FROM SCRATCH
An artificial intelligence created at Northwestern University was given a simple prompt: design a robot that can walk on a flat surface.
CHRONIC ILLNESS BLAMED FOR U.S.’s DRAMATIC DROP IN LIFE EXPECTANCY
More Americans are dying earlier, and the U.S. is losing ground to peer countries in its effort to keep its population alive.
STEEL COMPANY GOES ALL IN ON NUCLEAR FUSION
In the first agreement between a manufacturing company and fusion-energy research venture, Nucor—the largest steel producer in the U.S.—has formed a venture with Helion Energy, which is developing a nuclear fusion technology using water.
ELECTRODES GROWN INSIDE LIVING BRAINS
At Sweden’s Lund University, researchers have succeeded in growing tiny electrodes inside the brains of zebrafish and medicinal leeches. If scalable to humans, the devices could pave the road to new treatments for Alzheimer’s and Parkinson’s diseases and other brain-based conditions.
OZEMPIC, WEGOVY TIED TO STOMACH PARALYSIS, OTHER HEALTH ISSUES, ACCORDING TO NEW STUDY
New weight loss drugs that have skyrocketed in popularity after being embraced by Hollywood celebrities have been linked to three stomach conditions, including one condition that is not listed on the warning labels, according to a new study from British Columbia.